Updates

January 20, 2020January 20, 2020
Leronlimab Combo Shows Promise for Metastatic TNBC in Early Phase 1b/2 Trial Data

Investigational therapy leronlimab is showing promise as a potential therapy for people with CCR5-positive metastatic triple-negative breast cancer (mTNBC), early data from a Phase ... Read more
January 17, 2020January 21, 2020
New Method Using Sound Waves May Stop Breast Cancer Spread in Lymph Nodes, Mouse Study Shows

A new method that uses sound waves to release chemotherapy in lymph nodes invaded by breast cancer cells could offer a safer option ... Read more
January 14, 2020January 22, 2020
CytoDyn Files for FDA Breakthrough Therapy Status for Leronlimab for Metastatic TNBC

CytoDyn has requested breakthrough therapy designation from the U.S. Food and Drug Administration (FDA) for its investigational therapy leronlimab (PRO 140) as an adjuvant ... Read more
January 13, 2020January 13, 2020
Certain Genomic Tests May Soon Be Reimbursable for Breast Cancer Patients in Germany

Techniker Krankenkasse, one of the largest healthcare insurers in Germany, will begin reimbursing their breast cancer patients for genomic tests, announced Agendia, a diagnostics company ... Read more
January 10, 2020January 10, 2020
Keytruda, Imprime PGG Combo Increases Overall Survival in Metastatic Triple-negative BC, Data Show

Treatment with Biothera Pharmaceutical‘s Imprime PGG appears to increase the sensitivity of chemotherapy-resistant metastatic triple-negative breast cancers (mTNBC) to the immune checkpoint inhibitor Keytruda (pembrolizumab), ... Read more

News

Arimidex ‘Highly Effective’ at Reducing Long-term Breast Cancer Rates in At-risk Women, Study Finds
January 8, 2020January 8, 2020
Postmenopausal women at increased risk of breast cancer are half as likely to develop ...
News

Enhertu Gets FDA Approval for Treatment of Advanced HER2-positive Breast Cancer
January 2, 2020January 3, 2020
The U.S. Food and Drug Administration (FDA) approved Enhertu (fam-trastuzumab deruxtecan-nxki) for the treatment ...
News

Seattle Genetics Seeks Tucatinib’s Approval by FDA for Advanced HER2-positive Breast Cancer
December 30, 2019January 6, 2020
Seattle Genetics has submitted an application requesting U.S. Food and Drug Administration (FDA) approval ...
News

FDA Grants Breakthrough Therapy Status to Tucatinib for Advanced HER2-Positive Breast Cancer
December 19, 2019January 15, 2020
The U.S. Food and Drug Administration (FDA) has granted breakthrough therapy designation to Seattle ...
News

TAVO Boosts Responses to Keytruda in Triple-negative Breast Cancer Patients, Interim Phase 2 Data Show
December 18, 2019January 15, 2020
Treatment with TAVO (intratumoral IL-12) appears to increase the sensitivity of previously treated advanced ...
News

Dosing Complete in Phase 2 Trial Evaluating Lymfactin for BC Treatment-Associated Lymphedema
December 17, 2019January 15, 2020
Herantis Pharma has completed patient dosing in its Phase 2 trial evaluating the investigational ...

Subscribe to our mailing list

Get regular updates delivered to your email box.

Thanks! Please check your email for a confirmation email.

Breast Cancer Index Identifies Women Likely to Benefit From Extended Hormone Therapy, Latest Data Show
December 16, 2019
The Breast Cancer Index, a molecular test developed by Biotheranostics, successfully identified a group ...
FDA Approves FoundationOne CDx as Companion Diagnostic Test for Piqray Treatment
December 11, 2019December 11, 2019
The U.S. Food and Drug Administration (FDA) has approved Foundation Medicine’s FoundationOne CDx as ...
HHS Grant to Advance Breast Cancer Screenings Based on Ultrasound
December 9, 2019
CHMP Favors Kadcyla Approval in EU for Certain HER2-positive Early Breast Cancer Patients
December 6, 2019
Weight Loss Surgery May Lower Risk of Breast Cancer, Research Suggests
December 4, 2019
More Than $850M Raised for Inflammatory Breast Cancer Research
November 15, 2019November 15, 2019

Fertility Clinics and Breast Cancer ‘Previvor’ Team Up to Raise Awareness About Genetic Risk of Disease
November 13, 2019
For patients with gene mutations that increase their risk for diseases such as breast ...
Blood Test May Identify Breast Cancer Years Before Symptoms Appear, Pilot Study Suggests
November 11, 2019November 11, 2019
Most Breast Cancers Found by Hand, MammaCare Researchers Say
November 8, 2019November 8, 2019
First Patient Dosed in Phase 3 Trial of Tucatinib-Kadcyla Combo for Advanced HER2-Positive Breast Cancer
November 6, 2019

Hormone Therapy Has More Long-term Impact on Quality of Life Than Chemo, Study Suggests
November 4, 2019
Challenging conventional wisdom, new findings suggest that hormone therapy may have a greater impact ...
Pathologist Creates Program Allowing Patients to Face Their Cancer Head-on
November 1, 2019December 30, 2019
Seattle Genetics’ Tucatinib Extends Survival Outcomes in Metastatic HER2-positive Breast Cancer Patients, Phase 2 Trial Shows
October 30, 2019

News

FDA Supports Use of Anti-diarrheal Medications with Nerlynx
October 28, 2019October 28, 2019
The U.S. label of Nerlynx (neratinib), a treatment for early stage HER2-positive breast cancer, now includes ...
News

Bempegaldesleukin-Opdivo Combo Leads to Prolonged Responses in TNBC Patients, Phase 1/2 Trial Shows
October 25, 2019November 11, 2019
Bempegaldesleukin (bempeg, NKTR-214) in combination with Opdivo (nivolumab) leads to prolonged treatment responses in ...
News

Daiichi Sankyo Files New Drug Application for DS-8201 in Japan
October 23, 2019October 24, 2019
Daiichi Sankyo has submitted an application to Japanese regulatory authorities asking that its investigational ...
News

Trastuzumab Deruxtecan Gets FDA Priority Review for Metastatic HER2-Positive Breast Cancer
October 21, 2019December 30, 2019
The U.S. Food and Drug Administration (FDA) has granted priority review to the application ...
News

Keytruda-chemo Combo Best for Clearing Tumors in Early TNBC, Latest Trial Data Show
October 18, 2019October 28, 2019
Adding the immunotherapy Keytruda (pembrolizumab) to chemotherapy increases the number of women with early ...
News

Kisqali-Faslodex Combo Prolongs Survival of Postmenopausal Women with Advanced Breast Cancer, Phase 3 Trial Shows
October 16, 2019
Kisqali (ribociclib) in combination with Faslodex (fulvestrant) prolongs the survival of postmenopausal women with ...
News

Hormone Therapy-Chemo Combo Reduces Risk of Tumor Return in Highly Recurrent Breast Cancer, Phase 3 Trial Shows
October 14, 2019October 14, 2019
Using chemotherapy in combination with hormone therapy in women with highly recurring forms of breast cancer reduces ...
News

Terranea Resort Turns Pink for National Breast Cancer Awareness Month
October 9, 2019
In observance of National Breast Cancer Awareness Month, the Los Angeles oceanfront resort Terranea ...
News

Veliparib-Chemo Combo Prolongs Survival Without Disease Progression in Certain Advanced Breast Cancer Patients, Phase 3 Trial Shows
October 7, 2019
Veliparib in combination with chemotherapy significantly prolongs survival without disease progression in women with ...
News

Verzenio-Faslodex Combo Prolongs Survival of Women with Advanced Breast Cancer, Phase 3 Trial Shows
October 4, 2019October 7, 2019
Verzenio (abemaciclib) in combination with Faslodex (fulvestrant) prolongs the survival of women with HR-positive, ...
News

PINKTOBER Events at Hard Rock Promote Breast Cancer Awareness
October 2, 2019
Marking 20 years of support for breast cancer awareness and research, Hard Rock International has kicked ...
News

First Patients Dosed in Phase 1 Trial Testing ARV-471 in Advanced, ER-Positive Breast Cancer
September 30, 2019
The first patients have been dosed in a Phase 1 trial evaluating Arvinas‘ experimental ...
News

Mylan Launches Generic Version of Faslodex Injection in the US
September 27, 2019October 16, 2019
The U.S. Food and Drug Administration has approved Mylan‘s generic version of AstraZeneca‘s Faslodex ...
News

For Breast Cancer Awareness Month, Life Image Offering Free Access to Mammosphere App
September 25, 2019October 7, 2019
Because access to prior mammograms is critical for women during all stages of breast ...
News

New Herceptin-Perjeta Formulation Shows Promising Safety and Pharmacokinetic Profile, Phase 3 Trial Shows
September 23, 2019
When given together with Herceptin (trastuzumab) at a fixed dose through an under-the-skin (subcutaneous) ...
News

FDA OKs Use of Tool to Predict Patient Response to New Form of Cisplatin in Planned Phase 3 Study
September 20, 2019September 20, 2019
The U.S. Food and Drug Administration (FDA) has approved use of a device, called ...
News

Herceptin Developers Granted 2019 Lasker-DeBakey Research Award
September 18, 2019
The 2019 Lasker-DeBakey Clinical Medical Research Award has been granted to scientists H. Michael Shepard, ...
News

TNBC Patient Given Investigative Antibody, Leronlimab, Under Emergency Exception
September 16, 2019
A metastatic triple-negative breast cancer (TNBC) patient is being treated with CytoDyn’s investigational leronlimab ...

June 22, 2018June 22, 2018

Clinical Trial of Tamoxifen-based Gel in Reducing Breast Density Recruiting in US, EU

News

The ability of a gel containing a tamoxifen-byproduct to reduce breast density — associated with an increased risk of breast cancer — is now being evaluated in a recruiting Phase 3 clinical trial. Approximately half of women in ... Read more

Subscribe to our mailing list

Pin It on Pinterest